Merck Advances Pediatric Oncology with Innovative ADC Modeling
Merck leveraged ADC modeling and pediatric ADC dose optimization to enable FDA acceptance and advance…
Certara2025年12月12日
Expedited Pharmacometrics Regulatory Submissions
Certara delivers complete, compliant pharmacometric regulatory submission packages in just 4–6 weeks, eliminating the PMx…
Certara2025年12月8日
Certara Cuts Pharmacometrics Submission Timelines in Half: New Expedited Service Accelerates Global Regulatory Filings
Certara launches an expedited Pharmacometrics (PMx) Regulatory Submission service that cuts submission timelines in half.
Certara2025年12月3日
History and Evolution of Innovations in Clinical Pharmacology
This paper reviews how decades of scientific and technological advances have transformed clinical pharmacology and…
Danielle Pillsbury2025年11月26日
Modeling amyloid plaque turnover dynamics improves characterization of drug effects
Researchers modeled how amyloid plaques form and clear in Alzheimer’s disease, helping explain how treatments…
Certara2025年11月26日
10 Strategic Foundations for Early Drug Development
Discover effective Early Drug Development strategies to navigate early development with confidence and clarity. Download…
Certara2025年11月26日
Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges
The paper reviews current applications of pediatric PBPK across therapeutic areas and outlines where PBPK…
Certara2025年11月21日
A Guide to the FDA Announcement to Phase Out Animal Testing for Drugs
The FDA is phasing out animal testing of new drugs. Learn how Certara’s Non-Animal Navigator™…
Certara2025年11月17日
Using M&S to Evaluate Oncology Drug Dosing
Learn how modeling & simulation improves oncology drug dosing, optimizing safety, efficacy, and personalized treatment…
Certara2025年11月14日
